Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

被引:18
作者
Schjesvold, Fredrik [1 ,2 ]
Bringhen, Sara [3 ]
G. Richardson, Paul [4 ]
Perrot, Aurore [5 ]
Leleu, Xavier [6 ,7 ]
Moreau, Philippe [8 ]
A. Dimopoulos, Meletios [9 ]
Hulin, Cyrille [10 ]
Tekle, Christina [11 ]
Foster, Meredith C. [12 ]
Poole, Elizabeth M. [12 ]
van de Velde, Helgi [11 ]
Facon, Thierry [13 ]
机构
[1] Univ Oslo, Oslo Myeloma Ctr, Dept Haematol, Oslo Univ Hosp, Oslo, Norway
[2] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway
[3] Univ Torino, Azienda Osped Univ Citta Salute & Sci Torino, Div Hematol, Myeloma Unit, Turin, Italy
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Univ Toulouse, UPS, Serv Hematol, CHU Toulouse,IUCT O, Toulouse, France
[6] CHU, Serv Hematol & Therapie Cellulaire, F-1402 Poitiers, France
[7] CIC Inserm, F-1402 Poitiers, France
[8] Univ Nantes, Nantes, France
[9] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[10] Hop Haut Leveque CHU, Bordeaux, France
[11] Sanofi Oncol, Cambridge, MA USA
[12] Global Med Affairs, Sanofi Genzyme, Cambridge, MA USA
[13] Hopital Claude Huriez, Lille, France
关键词
D O I
10.1002/ajh.26319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E423 / E427
页数:5
相关论文
共 8 条
[1]   Defining the vulnerable patient with myeloma-a frailty position paper of the European Myeloma Network [J].
Cook, Gordon ;
Larocca, Alessandra ;
Facon, Thierry ;
Zweegman, Sonja ;
Engelhardt, Monika .
LEUKEMIA, 2020, 34 (09) :2285-2294
[2]   Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma [J].
Facon, Thierry ;
Niesvizky, Ruben ;
Mateos, Maria-Victoria ;
Siegel, David ;
Rosenbaum, Cara ;
Bringhen, Sara ;
Weisel, Katja ;
Ho, P. Joy ;
Ludwig, Heinz ;
Kumar, Shaji ;
Wang, Kenneth ;
Obreja, Mihaela ;
Yang, Zhao ;
Klippel, Zandra ;
Mezzi, Khalid ;
Goldrick, Amanda ;
Tekle, Christina ;
Dimopoulos, Meletios A. .
BLOOD ADVANCES, 2020, 4 (21) :5449-5459
[3]   A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial [J].
Facon, Thierry ;
Dimopoulos, Meletios A. ;
Meuleman, Nathalie ;
Belch, Andrew ;
Mohty, Mohamad ;
Chen, Wen-Ming ;
Kim, Kihyun ;
Zamagni, Elena ;
Rodriguez-Otero, Paula ;
Renwick, William ;
Rose, Christian ;
Tempescul, Adrian ;
Boyle, Eileen ;
Manier, Salomon ;
Attal, Michel ;
Moreau, Philippe ;
Macro, Margaret ;
Leleu, Xavier ;
Chretien, Marie Lorraine ;
Ludwig, Heinz ;
Guo, Shien ;
Sturniolo, Michael ;
Tinel, Antoine ;
Monzini, Mara Silvia ;
Costa, Bruno ;
Houck, Vanessa ;
Hulin, Cyrille ;
Mary, Jean Yves .
LEUKEMIA, 2020, 34 (01) :224-233
[4]   Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone [J].
Lee, Ho Sup ;
Kim, Kihyun ;
Lee, Je-Jung ;
Yoon, Sung-Soo ;
Bang, Soo-Mee ;
Kim, Jin Seok ;
Eom, Hyeon-Seok ;
Yoon, Dok Hyun ;
Lee, Yoojin ;
Shin, Ho-Jin ;
Park, Yong ;
Jo, Jae-Cheol ;
Lee, Won Sik ;
Do, Young Rok ;
Mun, Yeung-Chul ;
Lee, Mark Hong ;
Kim, Hyo Jung ;
Kim, Sung-Hyun ;
Kim, Min Kyoung ;
Lim, Sung-Nam ;
Park, Seong Kyu ;
Yi, Jun Ho ;
Lee, Jae Hoon ;
Min, Chang-Ki .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (01) :81-91
[5]   External validation of the FIRST trial's simplified frailty score in a population-based cohort [J].
Mian, Hira S. ;
Giri, Smith ;
Wildes, Tanya M. ;
Balitsky, Amaris K. ;
McCurdy, Arleigh ;
Pond, Gregory R. ;
Sivapathasundaram, Branavan ;
Seow, Hsien .
LEUKEMIA, 2021, 35 (06) :1823-1827
[6]   Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study [J].
Moreau, Philippe ;
Attal, Michel ;
Hulin, Cyrille ;
Arnulf, Bertrand ;
Belhadj, Karim ;
Benboubker, Lotfi ;
Bene, Marie C. ;
Broijl, Annemiek ;
Caillon, Helene ;
Caillot, Denis ;
Corre, Jill ;
Delforge, Michel ;
Dejoie, Thomas ;
Doyen, Chantal ;
Facon, Thierry ;
Sonntag, Cecile ;
Fontan, Jean ;
Garderet, Laurent ;
Jie, Kon-Siong ;
Karlin, Lionel ;
Kuhnowski, Frederique ;
Lambert, Jerome ;
Leleu, Xavier ;
Lenain, Pascal ;
Macro, Margaret ;
Mathiot, Claire ;
Orsini-Piocelle, Frederique ;
Perrot, Aurore ;
Stoppa, Anne-Marie ;
van de Donk, Niels W. C. J. ;
Wuilleme, Soraya ;
Zweegman, Sonja ;
Kolb, Brigitte ;
Touzeau, Cyrille ;
Roussel, Murielle ;
Tiab, Mourad ;
Marolleau, Jean-Pierre ;
Meuleman, Nathalie ;
Vekemans, Marie-Christiane ;
Westerman, Matthijs ;
Klein, Saskia K. ;
Levin, Mark-David ;
Fermand, Jean Paul ;
Escoffre-Barbe, Martine ;
Eveillard, Jean-Richard ;
Garidi, Reda ;
Ahmadi, Tahamtan ;
Zhuang, Sen ;
Chiu, Christopher ;
Pei, Lixia .
LANCET, 2019, 394 (10192) :29-38
[7]   Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report [J].
Palumbo, Antonio ;
Bringhen, Sara ;
Mateos, Maria-Victoria ;
Larocca, Alessandra ;
Facon, Thierry ;
Kumar, Shaji K. ;
Offidani, Massimo ;
McCarthy, Philip ;
Evangelista, Andrea ;
Lonial, Sagar ;
Zweegman, Sonja ;
Musto, Pellegrino ;
Terpos, Evangelos ;
Belch, Andrew ;
Hajek, Roman ;
Ludwig, Heinz ;
Stewart, A. Keith ;
Moreau, Philippe ;
Anderson, Kenneth ;
Einsele, Hermann ;
Durie, Brian G. M. ;
Dimopoulos, Meletios A. ;
Landgren, Ola ;
San Miguel, Jesus F. ;
Richardson, Paul ;
Sonneveld, Pieter ;
Rajkumar, S. Vincent .
BLOOD, 2015, 125 (13) :2068-2074
[8]   Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis [J].
Schjesvold, Fredrik ;
Richardson, Paul G. ;
Facon, Thierry ;
Alegre, Adrian ;
Spencer, Andrew ;
Jurczyszyn, Artur ;
Sunami, Kazutaka ;
Frenzel, Laurent ;
Min, Chang-Ki ;
Guillonneau, Sophie ;
Lin, Peggy L. ;
Le-Guennec, Solenn ;
Campana, Frank ;
van de Velde, Helgi ;
Bensfia, Samira ;
Bringhen, Sara .
HAEMATOLOGICA, 2021, 106 (04) :1182-1187